Loading patent…
AssigneeUniversity of Virginia Patent Foundation
InventorsKyle Hoehn, Webster L. Santos, Elizabeth S. Childress, Yumin Dai, Jacob Murray, Jose Santiago-Rivera
Estimating the term…
This disclosure provides compounds of Formula I, II, and III and pharmaceutically acceptable salts thereof for use as mitochondrial uncouplers, where the variables, e.g. R1-R9, X1, X2, and Y1 are defined in the specification. The disclosure also provides pharmaceutical compositions comprising a compound or pharmaceutically acceptable salt of Formula I, II, or III, alone or in combination with another active compound. Compounds and compositions of Formula I, II, and III are useful for treating or preventing certain conditions such as obesity, type II diabetes, fatty liver disease, insulin resistance, Parkinson's disease, ischemia reperfusion injury, heart failure, non-alcoholic fatty liver disease (NALFD), and non-alcoholic steatohepatitis (NASH). Compounds of Formula I, II, and III are also useful for regulating glucose homeostatis and insulin action.
A compound or pharmaceutically acceptable salt thereof, wherein the compound is
A compound of the formula:
Dependencies are inferred from the claim text.